BioLargo Gelecekteki Büyüme
Future kriter kontrolleri 2/6
BioLargo is forecast to grow earnings and revenue by 63.3% and 27.2% per annum respectively while EPS is expected to grow by 105.3% per annum.
Anahtar bilgiler
63.3%
Kazanç büyüme oranı
105.3%
EPS büyüme oranı
| Chemicals kazanç büyümesi | 17.3% |
| Gelir büyüme oranı | 27.2% |
| Gelecekteki özkaynak getirisi | n/a |
| Analist kapsamı | Low |
| Son güncelleme | 19 Aug 2024 |
Gelecekteki son büyüme güncellemeleri
Güncelleme yok
Recent updates
Kazanç ve Gelir Büyüme Tahminleri
| Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
|---|---|---|---|---|---|
| 12/31/2025 | 25 | -1 | N/A | N/A | 1 |
| 12/31/2024 | 20 | -3 | N/A | N/A | 1 |
| 6/30/2024 | 17 | -3 | -2 | -1 | N/A |
| 3/31/2024 | 13 | -4 | -3 | -2 | N/A |
| 12/31/2023 | 12 | -4 | -3 | -2 | N/A |
| 9/30/2023 | 10 | -4 | -3 | -2 | N/A |
| 6/30/2023 | 9 | -3 | -3 | -2 | N/A |
| 3/31/2023 | 9 | -3 | -2 | -2 | N/A |
| 12/31/2022 | 6 | -4 | -3 | -3 | N/A |
| 9/30/2022 | 5 | -6 | -4 | -4 | N/A |
| 6/30/2022 | 4 | -7 | -4 | -4 | N/A |
| 3/31/2022 | 3 | -7 | -4 | -4 | N/A |
| 12/31/2021 | 3 | -7 | -4 | -4 | N/A |
| 9/30/2021 | 3 | -6 | -4 | -4 | N/A |
| 6/30/2021 | 3 | -7 | -4 | -4 | N/A |
| 3/31/2021 | 3 | -8 | -4 | -4 | N/A |
| 12/31/2020 | 2 | -8 | -4 | -4 | N/A |
| 9/30/2020 | 2 | -9 | -5 | -5 | N/A |
| 6/30/2020 | 2 | -11 | -5 | -5 | N/A |
| 3/31/2020 | 2 | -10 | -4 | -4 | N/A |
| 12/31/2019 | 2 | -11 | -4 | -4 | N/A |
| 9/30/2019 | 2 | -10 | -4 | -4 | N/A |
| 6/30/2019 | 2 | -9 | -4 | -4 | N/A |
| 3/31/2019 | 1 | -10 | -4 | -4 | N/A |
| 12/31/2018 | 1 | -10 | -4 | -4 | N/A |
| 9/30/2018 | 1 | -10 | -4 | -4 | N/A |
| 6/30/2018 | 1 | -10 | -4 | -4 | N/A |
| 3/31/2018 | 1 | -9 | N/A | -4 | N/A |
| 12/31/2017 | 1 | -9 | N/A | -4 | N/A |
| 9/30/2017 | 0 | -9 | N/A | -4 | N/A |
| 6/30/2017 | 0 | -9 | N/A | -4 | N/A |
| 3/31/2017 | 0 | -9 | N/A | -4 | N/A |
| 12/31/2016 | 0 | -8 | N/A | -4 | N/A |
| 9/30/2016 | 0 | -7 | N/A | -3 | N/A |
| 6/30/2016 | 0 | -6 | N/A | -3 | N/A |
| 3/31/2016 | 0 | -6 | N/A | -3 | N/A |
| 12/31/2015 | 0 | -5 | N/A | -2 | N/A |
| 9/30/2015 | 0 | -5 | N/A | -2 | N/A |
| 6/30/2015 | 0 | -4 | N/A | -2 | N/A |
| 3/31/2015 | 0 | -3 | N/A | -1 | N/A |
| 12/31/2014 | 0 | -4 | N/A | -2 | N/A |
| 9/30/2014 | 0 | -4 | N/A | -2 | N/A |
| 6/30/2014 | 0 | -3 | N/A | -1 | N/A |
| 3/31/2014 | 0 | -3 | N/A | -1 | N/A |
| 12/31/2013 | 0 | -3 | N/A | -1 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: BLGO is forecast to remain unprofitable over the next 3 years.
Kazançlar ve Piyasa: BLGO is forecast to remain unprofitable over the next 3 years.
Yüksek Büyüme Kazançları: BLGO is forecast to remain unprofitable over the next 3 years.
Gelir ve Pazar: BLGO's revenue (27.2% per year) is forecast to grow faster than the US market (8.9% per year).
Yüksek Büyüme Geliri: BLGO's revenue (27.2% per year) is forecast to grow faster than 20% per year.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: Insufficient data to determine if BLGO's Return on Equity is forecast to be high in 3 years time